Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_03-cv-05669/USCOURTS-cand-5_03-cv-05669-25/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

[SEE SIGNATURE PAGE FOR ATTORNEY 

NAMES] 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN JOSE DIVISION 

THE REGENTS OF THE UNIVERSITY OF 

CALIFORNIA 

Plaintiff, 

v. 

MICRO THERAPEUTICS, INC., a Delaware 

corporation, and DENDRON GmbH 

 Defendants and Third Party 

 Plaintiffs, 

v. 

BOSTON SCIENTIFIC CORPORATION and 

TARGET THERAPEUTICS, INC. 

 Third Party Defendants. 

 Case No: C03-05669 JW (RS) 

SECOND STIPULATED AMENDED

PROTECTIVE ORDER 

 To facilitate production and receipt of information during discovery in the abovereferenced action, Plaintiff The Regents of the University of California (“Plaintiff”), Defendants 

Micro Therapeutics, Inc. and Dendron GmbH (collectively “Micro Therapeutics” or “Defendants”), 

and Third-Party Defendants Boston Scientific Corporation and Target Therapeutics, Inc. 

(collectively “Boston Scientific” or “Third-Party Defendants”) have agreed and stipulated, through 

their respective counsel, to the entry of an order for the protection of trade secrets, private or other 

/ / / 

*E-FILED 2/12/07*

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 1 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

confidential research, development, or commercial information that may be produced or otherwise 

disclosed by them during the course of this action. 

Upon consideration of the record and proceedings herein and the stipulation of the parties: 

 IT IS ORDERED THAT; 

1. “Confidential Information” shall mean and include any documents (whether in hard 

copy or computer readable form), things, deposition testimony, responses to requests for 

production, or other information provided in discovery in this action (“Discovery Material”), which 

contain non-public, confidential or proprietary information, whether personal or business-related, 

including trade secrets, know-how or proprietary data, business, financial or commercial 

information, or medical information. Any party to this action, or a third-party producing Discovery 

Material in response to a subpoena (“Designating Party”) may designate its Confidential 

Information as CONFIDENTIAL. Confidential Information shall not include any Discovery 

Material that: 

 a. Has been or becomes lawfully in the possession of the party receiving the 

same (“Receiving Party”) through communications other than production or disclosure in this 

action; or 

 b. Has been or becomes part of the public domain by publication or otherwise 

and not due to any unauthorized act or omission on the part of the Receiving Party. 

1.1 There shall be two additional categories for those documents the parties feel have the 

highest degree of competitive sensitivity because they include commercial licenses or pertain to 

products that have not been released in the marketplace, involve planning, analysis, strategy and 

forward looking projections for products in development. 

 a. Parties may designate documents “Highly Restrictive: Outside Counsel 

Only.” The provisions of this Order applicable to Confidential documents shall also apply to 

documents marked “Highly Restrictive: Outside Counsel Only,” except that “Qualified Persons” 

under paragraph 5 shall be limited to paragraphs 5(a)-(d) (outside counsel), 5(f) (approved experts), 

5(g) (audiovisual vendors), 5(h) (the Court), and 5(i) (copying services). This designation shall 

apply only to the licenses of the parties and related documents. 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 2 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

3 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

 b. Documents marked “BSC Highly Restrictive: Outside Counsel Only,” shall 

be treated identically to “Highly Restrictive: Outside Counsel Only” documents, except that 

“Qualified Persons” under paragraph 5 shall be limited to Paragraphs 5(a)-(d) (outside counsel), 

5(e)(i) (The Regents Designated Personnel), 5(f) (approved experts), 5(g) (audiovisual vendors), 

5(h) (the Court), and 5(i) (copying services). 

2. The designation of Discovery Material in the form of documents, responses to 

admissions and interrogatories, or other tangible materials (including, without limitation, CDROMs and tapes) other than depositions or other pretrial testimony as CONFIDENTIAL shall be 

made by conspicuously affixing the appropriate legend on each page (or in the case of computer 

medium on the medium and its label and/or cover) to which the designation applies. To the extent 

practical, the CONFIDENTIAL designation shall be placed near the Bates number. If a document 

has more than one designation, the more restrictive designation applies. 

3. All designations of Discovery Materials as CONFIDENTIAL shall be made in good 

faith by the Designating Party and made at the time of disclosure, production, or tender to the 

Receiving Party, or at such other time as permitted by this Protective Order, provided that the 

inadvertent failure to so designate does not constitute a waiver of a claim to such designation, and a 

party may so designate Discovery Material thereafter subject to the protections of this Protective 

Order. 

4. Inadvertent (i.e., unintentional) production of documents (including physical objects) 

subject to work product immunity, the attorney-client privilege, the right of privacy, or any other 

applicable privilege, shall not constitute a waiver of the immunity or privilege, provided that the 

Designating Party shall notify the Receiving Party in writing of such inadvertent production 

promptly after the Designating Party discovers such inadvertent production. After notification is 

made, the Receiving Party shall immediately return to the Designating Party all copies of such 

inadvertently produced documents and shall immediately confirm in writing that all electronic 

copies have been deleted or destroyed. Nothing herein shall prevent the Receiving Party from 

challenging the propriety of the privilege or immunity designation by promptly filing an appropriate 

motion with the Court, but the Receiving Party shall not challenge the propriety of the privilege or 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 3 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

4 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

immunity designation on the grounds that the privilege or immunity was waived by production of 

the document. If no such challenge is brought, or if any such challenge is unsuccessful, no use shall 

be made of such documents during deposition or at trial, nor shall they be shown to anyone who 

was not given access to them prior to the request to return or destroy such documents. Furthermore, 

if no such challenge is brought, or if any such challenge is unsuccessful, the Receiving Party shall 

promptly confirm in writing that any analyses, memoranda or notes which were internally 

generated based upon such inadvertently produced information have been deleted and/or destroyed. 

5. Subject to paragraph 6 of this Protective Order, “Qualified Persons” having access to 

Discovery Material designated CONFIDENTIAL in this action are: 

 a. Fenwick & West LLP and its employees whose duties and responsibilities 

require access to such materials; 

 b(1). Heller Ehrman LLP and its employees whose duties and responsibilities 

require access to such materials; 

 b(2). Proskauer Rose LLP and its employees whose duties and responsibilities 

require access to such materials; 

 c. Goodwin Procter LLP and its employees whose duties and responsibilities 

require access to such materials; 

 d. Folger Levin & Kahn LLP and its employees whose duties and 

responsibilities require access to such materials; 

 e. For all parties, designated in-house representatives, whose names are listed 

below and who now have responsibility for maintaining, defending, or evaluating this litigation and 

paralegal or clerical employees whose duties and responsibilities require access to such materials: 

 i. For Plaintiff The Regents, the following persons shall have access to 

Discovery Material designated CONFIDENTIAL by any party, including MTI, Dendron, Boston 

Scientific and Target: Marty Simpson, University Counsel; Candace Voelker, Director, Office of 

Technology Transfer; Rita Hao, University Counsel; Bernadette McCafferty, Technology Transfer 

Officer for the University of California, Los Angeles; and paralegal or clerical employees whose 

duties and responsibilities require access to such materials (“The Regents Designated Personnel”); 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 4 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

5 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

 ii. For Defendants MTI and Dendron, the following persons shall have 

access to Discovery Material designated CONFIDENTIAL by The Regents: Cecily Hines, General 

Counsel for ev3; Thomas Wilder, Consultant for MTI and former President and CEO of MTI; 

Matthew Jenusaitis, President, Neurovascular Division; and Brian Strauss, Director of Research 

and Development for MTI; however, only Cecily Hines shall have access to Discovery Material 

designated CONFIDENTIAL by Boston Scientific, regardless of whether the Discovery Material is 

produced by The Regents or Boston Scientific; 

 iii. For Third Party Defendants, the following persons shall have access 

to Discovery Material designated CONFIDENTIAL by The Regents or MTI: Paul Sandman and 

Peter Gafner, in-house counsel for Boston Scientific and Target; 

 f. Independent consultants and expert witnesses retained by or for the parties 

and their counsel, including technical consultants and accounting or financial experts. 

 g. Vendors retained by or for the parties for preparing audiovisual aids, e.g., 

exhibits, models, graphics and videotapes for use in the court room, as well as their staff, 

stenographic, and clerical employees whose duties and responsibilities require access to such 

materials, who are not current employees of any party to this litigation or of any direct competitor 

of any party to this litigation; 

 h. The Court, Court personnel, and stenographic and video reporters engaged in 

proceedings incident to this action; and 

 i. Outside document copying services, and/or document coding or 

computerization services. 

6. Qualified Persons defined in paragraph 5(f) shall be allowed access to Confidential 

Information only after the Receiving Party has complied with the following procedure: 

 a. Before receiving any Confidential Information the person shall be furnished 

with a copy of this Protective Order and shall acknowledge, by executing the secrecy agreement 

form attached hereto as Exhibit A, that he or she has read this Protective Order, understands it, and 

agrees to be bound by it, and also expressly consents to the jurisdiction of this Court in connection 

with any proceeding or hearing relating to the enforcement of this Protective Order. 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 5 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

6 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

 b. Outside counsel for the Receiving Party shall furnish a copy of the executed 

secrecy agreement form to the Disclosing Party, along with a curriculum vitae of the person. 

 c. The Disclosing Party will have seven (7) business days to object in writing to 

the disclosure of Confidential Information to the particular person. If objection to the disclosure is 

made within seven (7) business days, the objecting party shall, no later than five (5) business days 

after objection, petition the Court for an order prohibiting the disclosure at issue. The objecting 

party shall have the burden of persuasion that disclosure should not be made. If an objection is 

made, no Confidential Information shall be made available to the particular person until after the 

Court rules that disclosure can be made, so long as the objection is followed by a timely petition. 

7. Confidential Information and the substance or contents thereof, including any notes, 

memoranda or other similar documents relating thereto, shall be used by a Receiving Party solely 

for the purpose of this action and any appeals therefrom, and shall not be disclosed or used in any 

other legal proceeding, including any legal proceeding, involving any of the parties. It shall not be 

made available, or disclosed, or summarized to any persons, including the parties, other than to 

Qualified Persons, and subject to the restrictions in this Protective Order. Confidential Information 

shall be maintained by the Receiving Party under the overall supervision of outside counsel. 

8. Any person in possession of Confidential Information shall exercise reasonably 

appropriate care with regard to the storage, custody or use of such Confidential Information in order 

to ensure that the confidential nature of the same is maintained. 

9. If Confidential Information is disclosed to anyone other than in a manner authorized 

by this Protective Order, the party responsible for such disclosure must immediately bring all 

pertinent facts relating to such disclosure to the attention of the Designating Party and make every 

reasonable effort to retrieve such Confidential Information and to prevent further disclosure. 

10. When Confidential Information is discussed, quoted or referred to in any deposition, 

the disclosing party shall ensure that only persons permitted by paragraph 5 of this Protective Order 

to have access to such Confidential Information are present. 

11. During the course of preparation for a deposition or testimony, a fact 

deponent/witness may be shown Confidential Information from another party’s Discovery 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 6 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

7 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

Materials that appears to be authored or received in the normal course of business by the 

deponent/witness. Use of Confidential Information during a deposition shall be subject to 

compliance with this Protective Order. 

12. Any deposition transcript containing Confidential Information shall be marked on 

the cover as CONFIDENTIAL as appropriate, and shall indicate as appropriate within the transcript 

what information has been so designated. Whenever possible, the stenographic reporter shall be 

requested to separate those portions of the transcript containing CONFIDENTIAL information and 

separately bind them from each other and from the non-confidential portions. However, a 

Designating Party may also designate any portion or all (if appropriate) of the transcript or exhibits 

as CONFIDENTIAL with page and line references as to the affected testimony, by so advising the 

deposition reporter (who shall accordingly indicate the designations in the transcripts or exhibits) 

and all parties in writing, within thirty (30) days after receipt of the transcript. Until thirty (30) 

days have passed after the receipt of any transcript, that entire transcript shall be deemed to be 

CONFIDENTIAL. It is understood that Qualified Persons pursuant to paragraph 5(f) may attend 

depositions and review deposition transcripts and exhibits. In the event of disagreement about the 

confidential status of a deposition transcript, it shall be treated as CONFIDENTIAL until this Court 

rules otherwise. 

13. Any pleading, paper or other documents filed in this action which contains or 

discloses Confidential Information shall be filed under seal in accordance with Civil Local Rule 79-

5 and Judge Ware’s Standing Orders. A Party shall designate information disclosed at a hearing or 

trial as Confidential Information by requesting the Court, at the time the information is proffered or 

adduced, to receive the information only in the presence of those persons designated to receive such 

information and court personnel, and to designate the transcript appropriately. 

14. Entering into, agreeing to and/or producing or received Confidential Information or 

otherwise complying with the terms of this Protective Order shall not: 

 a. Operate as an admission by any party that any Discovery Material designated 

as Confidential Information contains or reflects trade secrets or any other type of confidential or 

proprietary information entitled to protection under applicable law; 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 7 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

8 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

 b. Prejudice in any way the rights of any party to object to the production of 

documents it considers not subject to discovery, or operate as an admission to any party that the 

restrictions and procedures set forth herein constituted adequate protection for any particular 

information deemed by any party to be Confidential Information; 

 c. Prejudice in any way the rights of any party to object to the authenticity or 

admissibility into evidence of any document, testimony or the evidence subject to this Protective 

Order; 

 d. Prejudice in any way the rights of any party to seek a determination by the 

Court whether any Discovery Material or Confidential Information should be subject to the terms of 

this Protective Order; 

 e. Prejudice in any way the rights of any party to petition the Court for a further 

protective order relating to any purportedly Confidential Information; 

 f. Prejudice in any way the rights of any party to petition the Court for 

permission to disclose or use particular Confidential Information more broadly than would 

otherwise be permitted by the terms of this Protective Order; or 

 g. Prevent any Designating Party from agreeing to alter or waive the provisions 

or protection provided for herein with respect to any particular Discovery Material designated as 

Confidential Information by that party. 

15. The signing of this Protective Order or failure of a party, at the time it receives 

Discovery Materials designated as CONFIDENTIAL to challenge or object to the 

CONFIDENTIAL or designation shall not be deemed a waiver of its right to challenge or object to 

the designations at any later time. Any party may at any time challenge the designation of any 

Discovery Materials as CONFIDENTIAL and may request permission to use or disclose 

information with the CONFIDENTIAL designation other than as permitted, pursuant to this 

paragraph by serving (by facsimile transmission) a written request upon counsel for the Designating 

Party at least five (5) business days before the date of the proposed disclosure and by providing 

telephonic notice of such request on the same date as the facsimile is transmitted. Such request 

shall specifically identify the Confidential Information, including Bates label, sought to be 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 8 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

9 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

disclosed and the name, title and function of the person to whom disclosure is desired to be made. 

The Designating Party shall thereafter respond to the request in writing within five (5) business 

days after receipt of same. Absent good cause shown, a failure to respond within such time shall 

constitute consent to the request. If, where consent has been withheld, the parties are subsequently 

unable to agree on the terms and conditions of disclosure, the matter may be submitted to the Court 

for resolution by the party seeking disclosure. Disclosure shall be postponed until a ruling has been 

obtained from the Court. 

16. All provisions of this Protective Order restricting the use of information obtained 

during discovery shall continue to be binding on the parties and all persons who have received 

information under this Protective Order, after the conclusion of this action, including all appeals, 

until further Order of the Court, unless the parties agree otherwise in writing. Any and all originals 

and copies of Discovery Materials designated CONFIDENTIAL shall, at the request of the 

Designating Party, be returned to the party within sixty (60) days after a final judgment herein or 

settlement of this action, or, at the option of the Designating Party, destroyed in that time frame, 

except that outside counsel for each party may maintain in its files one copy of each pleading filed 

with the Court, each deposition transcript together with the exhibits marked at the deposition, one 

copy of each piece of correspondence, and documents constituting work product which were 

internally generated based upon or which include Confidential Information. In the event that 

outside counsel maintains such documents, it shall not disclose material maintaining any type of 

Confidential Information to any third party absent subpoena or court order. Upon receipt of any 

subpoena for such information, the party receiving the subpoena shall immediately notify outside 

counsel for the Designating Party of the subpoena so that the latter may protect its interests. In the 

event that documents are returned to or destroyed at the request of the Designating Party, the other 

party or its outside counsel shall certify in writing that all such documents have been returned or 

destroyed, as the case may be. 

17. Third parties who produce information in this action may avail themselves of the 

provisions of this Protective Order and Discovery Material produced by third parties shall be 

treated by the parties in conformance with this Protective Order. 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 9 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

10 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

18. Until such time as this Amended Protective Order has been entered by the Court, the 

parties agree that upon execution by the parties, it will be treated as though it had been “So 

Ordered.” 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 10 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

11 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

 Respectfully submitted, 

DATED: February 12, 2007 By: _____/s/__________________________ 

FENWICK & WEST LLP 

Lynn H. Pasahow (Bar No. 054283) 

lpasahow@fenwick.com 

Patrick E. Premo (Bar No. 184915) 

ppremo@fenwick.com 

Silicon Valley Center 

801 California Street 

Mountain View, California 94041 

Telephone: (650) 988-8500 

Attorneys for Plaintiff/Counter-defendant 

THE REGENTS OF THE UNIVERSITY OF 

CALIFORNIA 

 

DATED: February 12, 2007 By: __/s/_____________________________

HELLER EHRMAN LLP 

Michael K. Plimack (Bar No. 133869) 

Michael.Plimack@Hellerehrman.com 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

HELLER EHRMAN LLP 

John S. Skilton (Pro Hac Vice) 

John.Skilton@Hellerehrman.com 

David J. Harth (Pro Hac Vice) 

David.Harth@Hellerehrman.com 

Charles G. Curtis, Jr. (Pro Hac Vice) 

Charles.Curtis@Hellerehrman.com 

Michelle M. Umberger (Pro Hac Vice) 

Michelle.Umberger@Hellerehrman.com 

Gabrielle E. Bina (Pro Hac Vice) 

Gabrielle.Bina@Hellerehrman.com 

Sarah C. Walkenhorst (Pro Hac Vice) 

Sarah.Walkenhorst@Hellerehrman.com 

One East Main Street, Suite 201 

Madison, WI 53703 

Telephone: (608) 663-7460 

Facsimile: (608) 663-7499 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 11 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

12 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

Attorneys for Defendants/Counterclaimants and Third 

Party Plaintiffs MICRO THERAPEUTICS, INC. and 

DENDRON GmbH 

DATED: February 12, 2007 By: ___/s/_____________________________

PROSKAUER ROSE LLP 

Colin G. Sandercock (Pro Hac Vice) 

csandercock@proskauer.com 

1001 Pennsylvania Avenue NW 

Washington, D.C. 20004 

Telephone: (202) 416-6800 

Attorneys for Defendants/Counterclaimants and Third 

Party Plaintiffs MICRO THERAPEUTICS, INC. and 

DENDRON GmbH 

DATED: February 12, 2007 By: _/s/_______________________________

FOLGER LEVIN & KAHN LLP 

Michael F. Kelleher (SBN 165493) 

mkelleher@flk.com 

Julie L. Fieber (SBN 202857) 

jfieber@flk.com 

Embarcadero Center West 

275 Battery Street, 23rd Floor 

San Francisco, California 94111 

Telephone: (415) 985-2800 

Attorneys for Third Party Defendants 

BOSTON SCIENTIFIC CORPORATION and 

TARGET THERAPEUTICS, INC. 

DATED: February 12, 2007 By: ___/s/_____________________________

GOODWIN PROCTER LLP 

J. Anthony Downs (Pro Hac Vice) 

jdowns@goodwinprocter.com 

Roland H. Schwillinski (Pro Hac Vice) 

rschwillinski@goodwinprocter.com, 

Exchange Place 

Boston, Massachusetts 02109-2881 

Telephone: (617) 570-1000 

Attorneys for Third Party Defendants BOSTON 

SCIENTIFIC CORPORATION and TARGET 

THERAPEUTICS, INC. 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 12 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

13 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: _____________________, 2007 By:___________________________________ 

The Honorable Richard Seeborg 

United States Magistrate Judge 

 

 

 

February 12

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 13 of 14
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

14 

SECOND STIPULATED AMENDED PROTECTIVE ORDER CASE NO. C 03 05669 

JW (RS) 

EXHIBIT A 

SECRECY AGREEMENT 

 I, , state: 

 1. I reside at 

 . 

 2. I have read the Stipulated Amended Protective Order executed by counsel for the 

parties on __________, 2007 on behalf of The Regents of the University of California, Micro 

Therapeutics, Inc., Dendron GmbH, Boston Scientific Corporation and Target Therapeutics, Inc., in 

the preparation and conduct of the action entitled The Regents of the University of California v. 

Micro Therapeutics, Inc., et al., Civil Action No. C 03 05669 JW (RS), United States District 

Court, Northern District of California.

 3. I am fully familiar with and agree to comply with and be bound by the provisions of 

said Order. I understand that I am to retain all copies of any designated Confidential Information in 

a secure manner, and that all copies are to remain in my personal custody until I have completed my 

assigned duties, whereupon the copies and any writings prepared by me containing any designated 

Confidential Information are to be returned to counsel who provided me with such material. I will 

not divulge to persons other than those specifically authorized by said Order, and will not copy or 

use except solely for the purpose of these actions, any information obtained pursuant to said Order, 

except as provided in said Order. I agree to submit to the jurisdiction of the Court for purposes of 

enforcement of the Order. 

 I state under penalty of perjury under the laws of the United States of America that the 

foregoing is true and correct. 

 Executed on this ___ day of , 2007. 

 

 

Case 5:03-cv-05669-JW Document 432 Filed 02/12/07 Page 14 of 14